Risk factor
Poor trading liquidity
Profitability factor
Weak growth
About
Bajaj HealthCare Limited operates as a pharmaceutical enterprise primarily involved in the creation, production, and distribution of amino acids, dietary supplements, and essential active pharmaceutical ingredients (APIs). These products serve the pharmaceutical, nutraceutical, and food sectors, catering to both the Indian domestic market and global clientele. The company's extensive API collection encompasses a broad spectrum of therapeutic areas, addressing diverse health conditions. This includes, but is not limited to, treatments for diabetes, various infections (such as bacterial, viral, and fungal), cardiovascular diseases, neurological disorders (like anticonvulsants and nootropics), respiratory ailments (e.g., anti-asthmatics), and nutritional deficiencies. The portfolio also features anti-inflammatory drugs, antioxidants, and agents for iron chelation, among many others. Beyond its API offerings, Bajaj HealthCare also manufactures finished pharmaceutical formulations, available as tablets, capsules, and powders. The firm additionally provides impurities for various applications and actively exports its wide range of products. Established in 1993, Bajaj HealthCare Limited is headquartered in Thane, India.
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITDA, underpriced on P/FCF.